GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
-19.47%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$720M
AUM Growth
+$720M
(+13%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
31.46%
Top 10 Holdings %
Top 10 Hldgs %
61.08%
Holding
45
New
11
Increased
13
Reduced
9
Closed
6
Top Buys
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$48.4M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$36.5M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$35.3M |
| 4 |
Puma Biotechnology
PBYI
|
$28.1M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$26.4M |
Top Sells
| 1 |
Exelixis
EXEL
|
$36.8M |
| 2 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$28.5M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$18.9M |
| 4 |
argenx
ARGX
|
$10.6M |
| 5 |
Voyager Therapeutics
VYGR
|
$9.73M |
Sector Composition
| 1 | Healthcare | 95.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BioCryst Pharmaceuticals
BCRX
$1.74B
| $61.5M | 7.77% | 7,622,256 -356,019 | -4% | -$2.87M |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $49.3M | 6.23% | 5,567,348 +2,071,008 | +59% | +$18.3M |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $48.4M | 6.12% | +1,180,000 | New | +$48.4M |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $45.1M | 5.71% | 1,036,575 +118,808 | +13% | +$5.17M |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $44.5M | 5.63% | 2,752,256 +1,556,158 | +130% | +$25.2M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $42M | 5.31% | 1,225,000 +507,542 | +71% | +$17.4M |
|
7
Kura Oncology
KURA
$686M
| $38.9M | 4.91% | 2,769,527 +650,421 | +31% | +$9.13M |
|
8
United Therapeutics
UTHR
$13.8B
| $38.2M | 4.83% | 350,800 +50,800 | +17% | +$5.53M |
|
|
ZGNX
9
DELISTED
Zogenix, Inc.
ZGNX
| $36.5M | 4.61% | +1,000,000 | New | +$36.5M |
|
|
BOLD
10
DELISTED
Audentes Therapeutics, Inc
BOLD
| $35.3M | 4.47% | +1,657,873 | New | +$35.3M |
|
|
11
Puma Biotechnology
PBYI
$254M
| $28.1M | 3.55% | +1,379,700 | New | +$28.1M |
|
|
ARRY
12
DELISTED
Array Biopharma Inc
ARRY
| $26.4M | 3.33% | +1,850,000 | New | +$26.4M |
|
|
ONCE
13
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $24.7M | 3.12% | 630,600 +237,453 | +60% | +$9.29M |
|
|
FPRX
14
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $22.3M | 2.82% | 2,398,409 +750,656 | +46% | +$6.98M |
|
15
Cytokinetics
CYTK
$4.23B
| $20.1M | 2.53% | 3,173,288 +993,600 | +46% | +$6.28M |
|
16
Larimar Therapeutics
LRMR
$310M
| $17.8M | 2.25% | 3,598,392 +207,007 | +6% | +$1.02M |
|
|
FOMX
17
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $14.5M | 1.84% | 4,047,561 +17,293 | +0.4% | +$62.1K |
|
18
Savara
SVRA
$567M
| $13.8M | 1.74% | 1,819,195 -423,889 | -19% | -$3.21M |
|
19
TG Therapeutics
TGTX
$4.65B
| $12.3M | 1.55% | 3,000,000 +1,050,000 | +54% | +$4.31M |
|
|
RVLP
20
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $11.6M | 1.47% | +1,500,000 | New | +$11.6M |
|
|
CBAY
21
DELISTED
Cymabay Therapeutics
CBAY
| $11.2M | 1.41% | +1,418,489 | New | +$11.2M |
|
22
Tempest Therapeutics
TPST
$44M
| $10.2M | 1.29% | +1,288,093 | New | +$10.2M |
|
23
Krystal Biotech
KRYS
$4.27B
| $10.2M | 1.29% | +492,100 | New | +$10.2M |
|
24
Enanta Pharmaceuticals
ENTA
$180M
| $10.2M | 1.28% | 143,481 -66,919 | -32% | -$4.74M |
|
|
AMAG
25
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $10.1M | 1.28% | +664,681 | New | +$10.1M |
|